As respiratory illnesses rise and families prepare for holiday travel and gatherings, this is an important moment for practices to…
RSV
We’re excited to share that Merck’s new monoclonal antibody, Enflonsia™, is now part of the CPP portfolio. This addition reflects the…
RSV is a significant concern for infants and young children, often leading to hospitalizations. Surveys by the AAP show that…
The holiday season is a time for gathering with loved ones, but it also coincides with the peak of flu,…
The Centers for Disease Prevention and Control (CDC) are helping health care providers prepare their patients for the fall and…
With the new year beginning, the country is experiencing a surge in respiratory cases of the flu, COVID-19, and RSV….
Did you know there is now protection from RSV for infants for the 2023-2024 RSV season? There are two new…
As the weather gets cooler pediatric practices are preparing and staying busy as all three major respiratory viruses COVID-19, flu,…